ZA835204B
(en)
*
|
1982-07-19 |
1985-02-27 |
Pfizer |
N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
|
PH19293A
(en)
*
|
1982-11-15 |
1986-03-04 |
Pfizer |
Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
|
US4526889A
(en)
*
|
1982-11-15 |
1985-07-02 |
Pfizer Inc. |
Epimeric azahomoerythromycin A derivative, intermediates and method of use
|
US4492688A
(en)
*
|
1983-11-25 |
1985-01-08 |
Pfizer Inc. |
Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
|
JPS59225198A
(ja)
*
|
1983-05-23 |
1984-12-18 |
フアイザ−・インコ−ポレ−テツド |
抗菌性を有する9―デオキソ―9a―アザ―9a―ホモエリスロマイシンA,その製造方法および組成物
|
DE3461803D1
(en)
*
|
1983-05-23 |
1987-02-05 |
Pfizer |
Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin a and intermediates therefor
|
GR80277B
(en)
*
|
1983-09-06 |
1985-01-04 |
Pfizer |
Azahomoerythromycin b derivatives and intermediates therefor
|
US4465674A
(en)
*
|
1983-09-06 |
1984-08-14 |
Pfizer Inc. |
Azahomoerythromycin D derivative and intermediates therefor
|
US4518590A
(en)
*
|
1984-04-13 |
1985-05-21 |
Pfizer Inc. |
9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
|
US4512982A
(en)
*
|
1984-04-13 |
1985-04-23 |
Pfizer Inc. |
9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
|
US4921947A
(en)
*
|
1986-03-31 |
1990-05-01 |
Eli Lilly And Company |
Process for preparing macrolide derivatives
|
RU2066324C1
(ru)
|
1987-07-09 |
1996-09-10 |
Пфайзер Инк. |
Кристаллический дигидрат азитромицина и способ его получения
|
WO1989002271A1
(fr)
*
|
1987-09-10 |
1989-03-23 |
Pfizer |
Azithromycine et derives utilises comme agents anti-protozoaires
|
HRP20020231A2
(en)
*
|
2002-03-18 |
2003-12-31 |
Pliva D D |
ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
|
US6017894A
(en)
*
|
1988-08-03 |
2000-01-25 |
Schering Corporation |
Actinomadura fulva subsp uruguayensis and antimicrobial complex and antimicrobial compounds isolated therefrom
|
YU45590A
(sh)
*
|
1990-03-07 |
1992-07-20 |
PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. |
Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
|
US5912331A
(en)
*
|
1991-03-15 |
1999-06-15 |
Merck & Co., Inc. |
Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
US5189159A
(en)
*
|
1992-04-02 |
1993-02-23 |
Merck & Co., Inc. |
8a-AZA-8a-homoerythromycin cyclic iminoethers
|
US5215980A
(en)
*
|
1992-01-17 |
1993-06-01 |
Merck & Co., Inc. |
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
|
TW271400B
(fr)
*
|
1992-07-30 |
1996-03-01 |
Pfizer |
|
US5210235A
(en)
*
|
1992-08-26 |
1993-05-11 |
Merck & Co., Inc. |
Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
|
US5332807A
(en)
*
|
1993-04-14 |
1994-07-26 |
Merck & Co., Inc. |
Process of producing 8A- and 9A-azalide antibiotics
|
DK0699207T3
(da)
*
|
1993-05-19 |
1997-12-08 |
Pfizer |
Mellemprodukt til azithromycin
|
US5441939A
(en)
*
|
1994-03-04 |
1995-08-15 |
Pfizer Inc. |
3"-desmethoxy derivatives of erythromycin and azithromycin
|
WO1995028939A1
(fr)
*
|
1994-04-26 |
1995-11-02 |
Nobuhiro Narita |
Composition medicinale servant de medicament contre le cancer bronchopulmonaire 'non a petites cellules'
|
US5605889A
(en)
*
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
ES2163504T5
(es)
*
|
1994-05-06 |
2008-05-16 |
Pfizer Inc. |
Formas de dosificacion de liberacion controlada de azitromicina.
|
ES2122905B1
(es)
*
|
1996-07-11 |
1999-11-16 |
Astur Pharma Sa |
Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
|
PT102006B
(pt)
*
|
1997-05-19 |
2000-06-30 |
Hovione Sociedade Quimica S A |
Novo processo de preparacao de azitromicina
|
HN1998000074A
(es)
*
|
1997-06-11 |
1999-01-08 |
Pfizer Prod Inc |
Derivados de macrolidos c-4 sustituidos
|
HN1998000086A
(es)
*
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
JP2003512290A
(ja)
*
|
1997-09-10 |
2003-04-02 |
メルク エンド カムパニー インコーポレーテッド |
家畜抗菌剤としての8a−アザライド
|
AP1060A
(en)
|
1998-01-02 |
2002-04-23 |
Pfizer Prod Inc |
Novel erythromycin derivatives.
|
TW546302B
(en)
|
1998-05-08 |
2003-08-11 |
Biochemie Sa |
Improvements in macrolide production
|
EP1437360A3
(fr)
*
|
1998-08-19 |
2005-04-06 |
Pfizer Products Inc. |
C11-carbamates des macrolides antibactériens
|
US6043227A
(en)
*
|
1998-08-19 |
2000-03-28 |
Pfizer Inc. |
C11 carbamates of macrolide antibacterials
|
CA2245398C
(fr)
*
|
1998-08-21 |
2002-01-29 |
Apotex Inc. |
Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention
|
ES2243066T3
(es)
|
1998-09-22 |
2005-11-16 |
Pfizer Products Inc. |
Antibioticos de carbamato y carbazato cetolida.
|
ID28286A
(id)
*
|
1998-11-03 |
2001-05-10 |
Pfizer Prod Inc |
Antibiotik-antibiotik makrolida baru
|
UA70972C2
(uk)
*
|
1998-11-20 |
2004-11-15 |
Пфайзер Продактс Інк. |
13-членні азаліди і їх застосування як антибіотиків
|
SI20639A
(sl)
|
1998-11-30 |
2002-02-28 |
Teva Pharmaceutical Industries Ltd. |
Etanolat azitromicina, postopek za njegovo pripravo in njegovi farmacevtski sestavki
|
AU6484199A
(en)
|
1998-12-10 |
2000-06-26 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
TR200102128T2
(tr)
*
|
1999-01-27 |
2001-12-21 |
Pfizer Products Inc. |
Ketolid antibiyotikler
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
CA2373117C
(fr)
*
|
1999-05-24 |
2006-02-28 |
Pfizer Products Inc. |
Derives de 13-methyl-erythromycine
|
US6465437B1
(en)
*
|
1999-06-30 |
2002-10-15 |
Pfizer Inc. |
Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
|
US6764996B1
(en)
|
1999-08-24 |
2004-07-20 |
Abbott Laboratories |
9a-azalides with antibacterial activity
|
EP1101769A3
(fr)
|
1999-11-18 |
2001-10-24 |
Pfizer Products Inc. |
Dérivés de l'érythromycine contenant de l'azote
|
ES2177373B1
(es)
|
1999-11-26 |
2003-11-01 |
Astur Pharma Sa |
Preparacion de azitromicina en su forma no cristalina
|
CA2396426A1
(fr)
*
|
2000-01-04 |
2001-07-12 |
Teva Pharmaceutical Industries Ltd. |
Procede de preparation d'azithromycine dihydratee
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
DE10030781A1
(de)
*
|
2000-06-29 |
2002-01-17 |
Hassan Jomaa |
Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
|
US6403776B1
(en)
|
2000-07-05 |
2002-06-11 |
Pfizer Inc. |
Synthesis of carbamate ketolide antibiotics
|
ES2260047T3
(es)
|
2000-07-25 |
2006-11-01 |
Laboratorio Silanes, S.A. De C.V. |
Proceso de etapa unica para la preparacion de 7,16-deoxi-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihidroxi-6-etil-3,5,9,11,13,15-hexametilbiciclo(11.2.1)hexadeca-1(2)-en-ona y obtencion de una forma nueva de 9-deoxo-9a-metil-9a-homoeritromicina a.
|
US20020115621A1
(en)
*
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
WO2002015842A2
(fr)
*
|
2000-08-23 |
2002-02-28 |
Wockhardt Limited |
Procede de preparation d'azithromycine anhydre
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
HU229488B1
(hu)
|
2000-11-27 |
2014-01-28 |
Sandoz Ag |
Eljárás makrolid hidrátok elõállítására
|
US20020197314A1
(en)
*
|
2001-02-23 |
2002-12-26 |
Rudnic Edward M. |
Anti-fungal composition
|
HRP20010301A2
(en)
*
|
2001-04-27 |
2001-12-31 |
Pliva D D |
New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
|
IL158059A0
(en)
|
2001-04-27 |
2004-03-28 |
Pfizer Prod Inc |
Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
|
EP1671978A1
(fr)
|
2001-05-22 |
2006-06-21 |
Pfizer Products Inc. |
Nouvelle forme cristalline de l'azithromycine
|
US6861413B2
(en)
*
|
2001-05-22 |
2005-03-01 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
DE60209704T2
(de)
*
|
2001-05-22 |
2006-11-16 |
Pfizer Products Inc., Groton |
Neue kristallforme von azithromycin
|
GEP20063812B
(en)
*
|
2001-08-21 |
2006-05-10 |
Pfizer Prod Inc |
Single dose azithromycin for treating respirator infections
|
US20080149521A9
(en)
*
|
2001-10-18 |
2008-06-26 |
Michael Pesachovich |
Methods of stabilizing azithromycin
|
US6764997B2
(en)
*
|
2001-10-18 |
2004-07-20 |
Teva Pharmaceutical Industries Ltd. |
Stabilized azithromycin compositions
|
US7182915B2
(en)
*
|
2001-11-30 |
2007-02-27 |
Bristol-Myers Squibb Company |
Pipette configurations and arrays thereof for measuring cellular electrical properties
|
US20040186063A1
(en)
*
|
2002-02-15 |
2004-09-23 |
Hans-Jurgen Gutke |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
US20050171342A1
(en)
*
|
2002-02-15 |
2005-08-04 |
Michael Burnet |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
WO2003070254A1
(fr)
*
|
2002-02-15 |
2003-08-28 |
Sympore Gmbh |
Conjugues antibiotiques
|
EP1483579A4
(fr)
*
|
2002-02-15 |
2006-07-12 |
Merckle Gmbh |
Conjugues de composes biologiquement actifs, methodes de preparation et d'utilisation des conjugues, formulation et applications pharmaceutiques obtenues a partir desdits conjugues
|
AU2003217676B2
(en)
|
2002-02-22 |
2009-06-11 |
Takeda Pharmaceutical Company Limited |
Active agent delivery systems and methods for protecting and administering active agents
|
JPWO2003072589A1
(ja)
*
|
2002-02-26 |
2005-06-16 |
明治製菓株式会社 |
新規15員環アザライド及び新規16員環ジアザライド誘導体とその製造法
|
ITMI20021209A1
(it)
*
|
2002-06-04 |
2003-12-04 |
Chemi Spa |
Processo di preparazione di azitromicina ad elevata purezza
|
AU2003245504A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Andrx Corporation |
Pharmaceutical compositions for drugs having ph-dependentsolubility
|
US6855813B2
(en)
*
|
2002-07-19 |
2005-02-15 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate
|
HRP20020614A2
(en)
*
|
2002-07-22 |
2004-06-30 |
PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. |
Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
|
US7670627B2
(en)
*
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
WO2004087729A1
(fr)
*
|
2003-03-25 |
2004-10-14 |
Teva Pharmaceutical Industries Ltd. |
Produits de degradation de l'azithromycine, et methodes permettant de les identifier
|
US6645941B1
(en)
*
|
2003-03-26 |
2003-11-11 |
Enanta Pharmaceuticals, Inc. |
6,11-3C-bicyclic 9a-azalide derivatives
|
ES2220229B1
(es)
*
|
2003-05-29 |
2005-10-16 |
Quimica Sintetica, S.A. |
Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
|
EP2529730A1
(fr)
*
|
2003-06-16 |
2012-12-05 |
ANDRX Pharmaceuticals LLC. |
Composition à libération prolongée orale
|
GB2395482A
(en)
*
|
2003-07-03 |
2004-05-26 |
Jubilant Organosys Ltd |
Process for preparing non-hygroscopic azithromycin dihydrate
|
US8425936B2
(en)
|
2003-07-21 |
2013-04-23 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
JP2006528189A
(ja)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質産物、その使用法および製剤
|
AU2004258953B2
(en)
|
2003-07-21 |
2011-02-10 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
CA2535177A1
(fr)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Pastille robuste
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
WO2005019238A1
(fr)
*
|
2003-08-22 |
2005-03-03 |
Meiji Seika Kaisha, Ltd. |
Nouveaux derives d'azalide et d'azalactam et procede permettant de produire ces derives
|
WO2005023184A2
(fr)
|
2003-08-29 |
2005-03-17 |
Advancis Pharmaceuticals Corporation |
Produit antibiotique, son utilisation et sa formulation
|
CA2538064C
(fr)
|
2003-09-15 |
2013-12-17 |
Advancis Pharmaceutical Corporation |
Antibiotique, son utilisation et sa formulation
|
US7276487B2
(en)
*
|
2003-09-23 |
2007-10-02 |
Enanta Pharmaceuticals, Inc. |
9a, 11-3C-bicyclic 9a-azalide derivatives
|
US20050101547A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Sadatrezaei Mohsen |
Stabilized azithromycin composition
|
WO2005053652A1
(fr)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Compositions medicamenteuses cristallines multiparticulaires contenant un poloxamere et un glyceride
|
CA2547239A1
(fr)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Formes posologiques multiparticulaires d'azithromycine obtenues par des procedes se deroulant en milieu liquide
|
BRPI0416534A
(pt)
*
|
2003-12-04 |
2007-01-09 |
Pfizer Prod Inc |
composições multiparticuladas com estabilidade melhorada
|
WO2005053639A2
(fr)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Formes multiparticulaires a liberation controlee produites avec des optimiseurs de dissolution
|
ES2600577T3
(es)
*
|
2003-12-04 |
2017-02-09 |
Bend Research, Inc. |
Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
|
DE602004014805D1
(de)
*
|
2003-12-04 |
2008-08-14 |
Pfizer Prod Inc |
Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
|
BRPI0416535A
(pt)
*
|
2003-12-04 |
2007-01-09 |
Pfizer Prod Inc |
processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
US7943585B2
(en)
|
2003-12-22 |
2011-05-17 |
Sandoz, Inc. |
Extended release antibiotic composition
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
US7468428B2
(en)
*
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
WO2006011160A1
(fr)
*
|
2004-06-28 |
2006-02-02 |
Alembic Limited |
Procede pour la preparation de clathrate d'isopropanol d'azithromycine monohydrate
|
EP1771158A4
(fr)
|
2004-07-02 |
2008-03-12 |
Advancis Pharmaceutical Corp |
Comprimé pour distribution par impulsion
|
WO2006004085A1
(fr)
*
|
2004-07-02 |
2006-01-12 |
Wakamoto Pharmaceutical Co., Ltd. |
Composition médicinale à base d'eau contenant de l'azithromycine et procédé servant à préparer celle-ci
|
US7683162B2
(en)
*
|
2004-08-30 |
2010-03-23 |
Taro Pharmaceutical Industries Limited |
Process of preparing a crystalline azithromycin monohydrate
|
US20060046970A1
(en)
*
|
2004-08-31 |
2006-03-02 |
Insite Vision Incorporated |
Topical otic compositions and methods of topical treatment of prevention of otic infections
|
BRPI0519135A2
(pt)
*
|
2004-12-21 |
2008-12-23 |
Pfizer Prod Inc |
macrolÍdeos
|
CN101228171A
(zh)
*
|
2005-07-26 |
2008-07-23 |
默克勒有限公司 |
作为5-脂氧化酶和环加氧酶抑制剂的吡咯里嗪和中氮茚化合物的大环内酯偶联物
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
JP5015016B2
(ja)
*
|
2006-02-07 |
2012-08-29 |
大正製薬株式会社 |
10a−アザライド化合物
|
US8299052B2
(en)
*
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
JP2010501541A
(ja)
|
2006-08-24 |
2010-01-21 |
ウォックハート リサーチ センター |
抗菌活性を有する新規マクロライド及びケトライド
|
US7704959B2
(en)
|
2006-10-03 |
2010-04-27 |
Dow Pharmaceutical Sciences |
Azithromycin for the treatment of nodular acne
|
US8293715B2
(en)
*
|
2007-08-06 |
2012-10-23 |
Taisho Pharmaceutical Co., Ltd. |
10a-Azalide compound crosslinked at 10a- and 12-positions
|
US20090062220A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched azithromycin
|
US8299035B2
(en)
*
|
2008-05-15 |
2012-10-30 |
Taisho Pharmaceutucal Co., Ltd. |
10a-azalide compound having 4-membered ring structure
|
EP2346509B1
(fr)
|
2008-10-07 |
2020-05-13 |
Horizon Orphan LLC |
Inhalation de lévofloxacine pour réduire une inflammation des poumons
|
US20170128481A9
(en)
|
2009-03-06 |
2017-05-11 |
Insite Vision Corporation |
Ocular treatment with reduced intraocular pressure
|
WO2011015219A1
(fr)
|
2009-08-06 |
2011-02-10 |
Shifa Pharmed Industrial Group Co. |
Procédé de purification d'azithromycine par séparation de ses produits de dégradation thermiques et/ou isomères
|
JP5851516B2
(ja)
|
2010-12-09 |
2016-02-03 |
ウォックハート リミテッド |
ケトライド化合物
|
AR085286A1
(es)
|
2011-02-21 |
2013-09-18 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrolido sustituido en la posicion c-4
|
JP5718488B2
(ja)
|
2011-03-01 |
2015-05-13 |
ウォックハート リミテッド |
ケトライド中間体の調製方法
|
EP2688900B1
(fr)
|
2011-03-22 |
2016-09-28 |
Wockhardt Limited |
Procédé de préparation de composés de cétolides
|
WO2013088274A1
(fr)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Composition d'azithromycine amorphe anhydre dépourvue de dihydrate d'azithromycine
|
MX2015008146A
(es)
|
2012-12-24 |
2016-01-20 |
Univ Ramot |
Agentes para tratar enfermedades geneticas derivadas de mutaciones sin sentido y metodos para identificarlas.
|
US9044508B2
(en)
|
2013-03-15 |
2015-06-02 |
Insite Vision Corporation |
Concentrated aqueous azalide formulations
|
US20150141328A1
(en)
*
|
2013-11-18 |
2015-05-21 |
The Schepens Eye Research Institute |
Stimulation of human meibomian gland function
|
AR102810A1
(es)
|
2014-08-18 |
2017-03-29 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrólido sustituido en la posición c-4
|
CN104910222B
(zh)
*
|
2015-06-29 |
2018-02-13 |
石药集团欧意药业有限公司 |
阿奇霉素新晶型化合物及其制备方法
|
CN105061528B
(zh)
*
|
2015-08-05 |
2017-10-17 |
浙江维康药业股份有限公司 |
一种阿奇霉素化合物及含有该化合物的阿奇霉素软胶囊
|